Effectiveness of Liver-Directed Therapy for the Management of Intractable Hypoglycemia in Metastatic Insulinoma
Authors:
- 15 June 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 49 (6) , 763-767
Abstract
Objective: The aim of the study was to evaluate efficacy of chemoembolization and radioembolization in treating patients with recurrent hypoglycemia secondary to metastatic insulinoma. Methods: A retrospective review was performed of all patients with metastatic insulinoma treated with liver-directed therapy (LDT) at a large academic medical center from January 1998 to August 2017. Primary outcomes included blood glucose levels, occurrence of symptomatic hypoglycemic episodes, and tumor imaging response rates. Results: Seven patients were identified (4 male patients). The mean age at the first LDT was 60.9 (standard deviation [SD], 9.2) years. The median follow-up was 1.8 years. Thirty-three sessions of LDT were performed including 30 sessions of chemoembolization and 3 sessions of radioembolization. Technical success rate was 97% (32/33 procedures) with an initial clinical success rate of 100%, defined as absence of recurrent symptomatic hypoglycemia within 1 month after first cycle of LDT and overall clinical success rate of 85%. Random daytime glucose levels increased from 75.0 (SD, 26) mg/dL to 152.8 (SD, 52.4) mg/dL after LDT. The mean time to recurrence of intractable hypoglycemia was 21 (SD, 9) months. No severe complications were reported. Conclusions: Liver-directed therapy with chemoembolization or radioembolization is effective for treatment of symptomatic hypoglycemia secondary to malignant insulinoma metastatic to liver.Keywords
This publication has 13 references indexed in Scilit:
- Integrating Radioembolization (90Y Microspheres) Into Current Treatment Options for Liver TumorsAmerican Journal of Clinical Oncology, 2012
- Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine TumorsJournal of Hematology & Oncology, 2011
- Management of Intractable Hypoglycemia With Yttirum-90 Radioembolization in a Patient With Malignant InsulinomaThe American Journal of the Medical Sciences, 2010
- Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapySurgery, 2008
- Short‐ and long‐term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinismClinical Endocrinology, 2007
- Update on the Management of Neuroendocrine Hepatic MetastasesJournal of Vascular and Interventional Radiology, 2006
- Malignant Metastatic Insulinoma—Postoperative Treatment and Follow‐upWorld Journal of Surgery, 2005
- Natural History of a Proinsulin-Secreting Insulinoma: From Symptomatic Hypoglycemia to Clinical DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2000
- Functioning Insulinoma—Incidence, Recurrence, and Long-Term Survival of Patients: A 60-Year StudyMayo Clinic Proceedings, 1991
- Insulinoma in seattle: 39 cases in 30 yearsThe American Journal of Surgery, 1980